FMR LLC - ONCOGENEX PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
FMR LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$168,000
-82.2%
75,532
-81.4%
0.00%
Q2 2015$944,000
-10.9%
405,302
-17.7%
0.00%
Q1 2015$1,059,000
-20.0%
492,454
-14.8%
0.00%
Q4 2014$1,323,000
+13.8%
577,934
+32.7%
0.00%
Q3 2014$1,163,000
-26.5%
435,441
+2.6%
0.00%
Q2 2014$1,582,000
+93.6%
424,213
+510.4%
0.00%
Q1 2014$817,000
-57.3%
69,495
-69.7%
0.00%
Q4 2013$1,914,000
-5.8%
229,549
+4.7%
0.00%
Q3 2013$2,032,000
-55.1%
219,196
-52.5%
0.00%
-100.0%
Q2 2013$4,523,000461,5290.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
Acrospire Investment Management LLC 5,200$5,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$46,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders